Scholars Central

Short communicationPublished 29 Aug 2020

One-year results of half-dose photodynamic therapy versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy

Authors: Vanchalearm Banchasakjaroen, P Jirarattanasopa

Journal of Translational Research

Volume 4 · Issue 3 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

To think about the adequacy of half-portion photodynamic Therapy (PDT) and 33% portion PDT in therapy in constant or repeat Central Serous Chorioretinopathy (CSC). Laser photocoagulation is commonly used to treat extrafoveal spillage. Nonetheless, interminable CSC, with expansive or undefined spillage, and CSC with subfoveal or juxtafoveal spillage are hard to treat with laser photocoagulation on account of trouble in confining the spillage point and the chance of genuine intricacies, for example, RPE decay, changeless scotoma and optional choroidal neovascularization (CNV).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Translational Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Translational Research
  • BylineArticles whose byline prints “Vanchalearm Banchasakjaroen”
  • BylineArticles whose byline prints “P Jirarattanasopa”